FDA staff wants Pfizer to keep black box warning on anti-smoking drug
October 14, 2014 at 09:10 AM EDT
Oct 14 (Reuters) - U.S. Food and Drug Administration staff recommended that Pfizer Inc keep a severe warning on its controversial quit-smoking drug Chantix.
